Monserrate Andrés E, Ryman Davis C, Ma Shengmei, Xiong Chengjie, Noble James M, Ringman John M, Morris John C, Danek Adrian, Müller-Sarnowski Felix, Clifford David B, McDade Eric M, Brooks William S, Darby David G, Masters Colin L, Weston Philip S J, Farlow Martin R, Graff-Radford Neill R, Salloway Stephen P, Fagan Anne M, Oliver Angela, Bateman Randall J
University of Puerto Rico School of Medicine, San Juan2Institute of Clinical and Translational Sciences, Washington University School of Medicine, St Louis, Missouri.
Department of Neurology, Washington University School of Medicine, St Louis, Missouri4Dominantly Inherited Alzheimer Network Clinical Core, Washington University School of Medicine, St Louis, Missouri.
JAMA Neurol. 2015 Mar;72(3):325-32. doi: 10.1001/jamaneurol.2014.3974.
This study assesses factors associated with the most common adverse event following lumbar puncture.
To identify factors associated with the risk, onset, and persistence of post-dural puncture headache (PDPH).
DESIGN, SETTING, AND PARTICIPANTS: We performed univariate and multivariable analyses of 338 lumbar punctures in the Dominantly Inherited Alzheimer Network observational study using linear mixed models, adjusting for participant-level and family-level random effects.
We directly evaluated associations of 3 post-lumbar puncture outcomes (immediate postprocedural headache, PDPH at 24-hour follow-up, and PDPH receiving a therapeutic blood patch) with participant age and sex, positioning, collection method, needle size, needle insertion site, and cerebrospinal fluid (CSF) volume collected.
The incidence of adverse events included 73 immediate postprocedural headaches (21.6%), 59 PDPHs at 24-hour follow-up (17.5%), and 15 PDPHs receiving a therapeutic blood patch (4.4%). Greater volume of CSF collected was associated with increased risk of immediate postprocedural headache, largely owing to a nonlinear increase in risk on collection of volumes above 30 mL (odds ratio, 3.73 for >30 mL and 0.98 for <17 mL). In contrast, collection of higher volumes showed a protective effect in decreasing rates of PDPH at 24-hour follow-up and rates of PDPH receiving a therapeutic blood patch (odds ratio, 0.35 per 10 mL). Although differences in needle size did not reach statistical significance, no participant in the 24G needle group received a therapeutic blood patch compared to 8 of 253 for the larger 22G needles.
Factors that acutely lower CSF pressure (eg, seated positioning or extracting very high volumes of CSF) may be associated with transient post-lumbar puncture headache, without increasing rates of persistent PDPH or therapeutic blood patch. Collection of up to 30 mL of CSF appears to be well tolerated and safe.
本研究评估了与腰椎穿刺后最常见不良事件相关的因素。
确定与硬膜穿刺后头痛(PDPH)的风险、发作及持续时间相关的因素。
设计、背景和参与者:在显性遗传阿尔茨海默病网络观察性研究中,我们对338例腰椎穿刺进行了单变量和多变量分析,采用线性混合模型,并对参与者水平和家庭水平的随机效应进行了调整。
我们直接评估了3种腰椎穿刺后结局(术后即刻头痛、24小时随访时的PDPH以及接受治疗性血补丁的PDPH)与参与者年龄、性别、体位、采集方法、针的规格、进针部位以及采集的脑脊液(CSF)量之间的关联。
不良事件的发生率包括术后即刻头痛73例(21.6%)、24小时随访时的PDPH 59例(17.5%)以及接受治疗性血补丁的PDPH 15例(4.4%)。采集的CSF量越大,术后即刻头痛的风险越高,这主要是由于采集量超过30 mL时风险呈非线性增加(>30 mL时比值比为3.73,<17 mL时为0.98)。相比之下,采集量较大对降低24小时随访时的PDPH发生率以及接受治疗性血补丁的PDPH发生率有保护作用(每10 mL比值比为0.35)。尽管针的规格差异未达到统计学显著性,但24G针组没有参与者接受治疗性血补丁,而22G大针组的253例中有8例接受了治疗性血补丁。
能急性降低CSF压力的因素(如坐位体位或抽取大量CSF)可能与短暂的腰椎穿刺后头痛相关,而不会增加持续性PDPH或治疗性血补丁的发生率。采集多达30 mL的CSF似乎耐受性良好且安全。